| Bioactivity | Ro 18-5364 is an inhibitor of gastric (H? + K?)-ATPase, which has the effect of inhibiting the activity of the enzyme. Ro 18-5364 has a very strong inhibitory effect on gastric mucosal (H? + K?)-ATPase, and the inhibitory effect is more significant at low pH. At the same time, there is no selectivity difference between the two enantiomers of (H? + K?)-ATPase, and its inhibitory effect can be studied and verified by a variety of experimental methods, including inhibition of enzyme activity, proton transport, and studies on its binding. |
| CAS | 101387-98-8 |
| Formula | C22H25N3O3S |
| Molar Mass | 411.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ro 18-5364, a potent new inhibitor of the gastric (H+ + K+)-ATPase [2]. Multimilligram enantioresolution of sulfoxide proton pump inhibitors by liquid chromatography on polysaccharide-based chiral stationary phase |
Ro 18-5364
CAS: 101387-98-8 F: C22H25N3O3S W: 411.52
Ro 18-5364 is an inhibitor of gastric (H? + K?)-ATPase, which has the effect of inhibiting the activity of the enzyme. R
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.